Erica Lee
Principal·F-Prime
Bio
Professional summary
Erica Lee is a Principal at F-Prime focused on investments in healthcare technology and services companies. Before joining F-Prime in 2021, she was an investment banking associate at Bank of America Merrill Lynch, where she advised on IPO and M&A transactions across healthcare IT. She holds a B.A. from Georgetown University in Finance and International Business.
Background
Career, education, and skills
Career history
- F-Prime CapitalPrincipal2021 – Present
- Bank of America Merrill LynchInvestment Banking Associate
Education
- Georgetown UniversityBA, Finance and International Business
Other partners at F-Prime
12 more profiles
Abdul Abdirahman
Principal
F-Prime
Principal investing in early-stage B2B software, fintech, and vertical SaaS.
Alex Pasteur
Partner
F-Prime
Alex Pasteur is a London-based Partner at F-Prime Capital focused on therapeutics and life sciences.
Anastasiya Sybirna, PhD
Senior Associate
F-Prime
Senior Associate on F-Prime's London healthcare investment team.
Bala Varadhan
Principal
F-Prime
Principal focused on early-stage crypto, blockchain and Web3 investments.
Benjamin Gorman
Principal
F-Prime
Principal investing in early-stage enterprise software and AI.
Betsy Mulé
Principal
F-Prime
Principal investing in enterprise technology and robotics.
Brett Cook
Partner
F-Prime
F-Prime Partner investing in healthcare technology and services companies.
Brian Yordy
Principal
F-Prime
Principal investing in biopharmaceutical and medical technology companies.
Carl Bradford Byers 🚑
Partner
F-Prime
F-Prime Partner and former athenahealth founding CFO investing in healthcare IT and digital health.
Carl Byers
Partner
F-Prime
Carl Byers is a Partner at F-Prime Capital with significant operating experience in healthcare IT, including as a founding team member and CFO of athenahealth.
Chance Mathisen
Associate
F-Prime
Associate focused on early-stage enterprise software investments.
Chong Xu
Partner
F-Prime
F-Prime partner focused on biopharma, medtech, company formation, and China healthcare opportunities.